Previous issue | Volume 89 | ESPE2018 | Next issue

57th Annual ESPE (ESPE 2018)

Athens, Greece
27 Sep 2018 - 29 Sep 2018

Card image cap
ESPE 2018 57th European Society for Paediatric Endocrinology Annual Meeting 27-29 September 2018 Athens, Greece

Working Groups

ESPE Diabetes Technology and Therapeutics Working Group

hrp0089wg4.3 | ESPE Diabetes Technology and Therapeutics Working Group | ESPE2018

Use of Apps for Physical Activity in Type 1 Diabetes

Kordonouri Olga

Global growth in the use of mobile phones, the so-called smartphones, makes them a powerful platform to help provide tailored health, delivered conveniently to patients. These devices are developing rapidly mainly with regard to information processing, design, features and connectivity with other devices. Modern treatment and monitoring of type 1 diabetes is being supported by rapid evolving technology as pumps for continuous subcutaneous insulin infusion and sensors for conti...

hrp0089wg4.4 | ESPE Diabetes Technology and Therapeutics Working Group | ESPE2018

The Future Role of Machine Learning and Computer Vision in Carbohydrate Estimation for Patients with Diabetes

Mougiakakou Stavroula

The recent advances in the areas of artificial intelligence, machine learning, computer vision, wearable sensors and smartphone technologies permitted the introduction of systems that allows the monitoring, analysis and assessment of food intake, in terms of energy and nutrient content. To empower diabetic patients the Diabetes Technology Research laboratory of the ARTORG Center at the University of Bern (Switzerland) has developed GoCARB, a smartphone App, capable to translat...

hrp0089wg4.5 | ESPE Diabetes Technology and Therapeutics Working Group | ESPE2018

Analyzing and Reporting of Sensor Glucose Levels

Nimri Revital

Background: Since the publication of the Diabetes Control and Complications Trial results two decades ago, glycated haemoglobin (A1c) has remained the only validated measurement of glycemic control and marker for future complications. The growing use of continuous glucose monitoring (CGM) has opened a new era of measuring and following glycemia and it associated outcomes. These new available glucose variables can provide a broader insight to personalized glyce...

hrp0089wg4.6 | ESPE Diabetes Technology and Therapeutics Working Group | ESPE2018

Updates on the Developments of Decision Support Systems for the Treatment of Diabetes

Phillip Moshe

With the increased number of patients with diabetes on one hand and the shortage of professional teams of health care providers (HCP) worldwide on the other hand, new ways of providing medical care to patients with diabetes are needed. Decision Support Systems (DSS) and emerging tools are developed in order to help HCP during patientsÂ’ office visits and to help patients navigate their own metabolic control between office visits. Recently, tools of DSS have been tested in ...

hrp0089wg4.7 | ESPE Diabetes Technology and Therapeutics Working Group | ESPE2018

Use of Social Media for Improving Glucose Control in Patients with Type 1 Diabetes Use of Social Media for Improving Glucose Control in Patients with Type 1 Diabetes

Petrovski Goran

One potential solution in improving Type 1 Diabetes (T1D) management is the use of technology, providing additional opportunities to support management, maintain and improve communication and engagement with healthcare services. Patients use Internet to search and interact with a community of patients with similar problems; to share clinical information; and to provide and receive support. Facebook with over 2.1 billion active monthly users worldwide is important source of inf...